Dr. Barry Dworkin

How many people need to be treated with expensive new cholesterol-lowering drug to prevent one heart attack?

Madely Health Headlines Commentary for June 11, 2015

Source:

FDA panel backs Amgen cholesterol drug for some patients

 

Related posts:

  1. Are US statin guidelines being too inclusive and leading to overtreatment?
  2. New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented
  3. New U.S guidelines for statin use for everyone over 40 needs careful consideration of risks vs benefits and is certainly not for everyone
  4. New blood thinners add value to stroke prevention and quality of life